This APMEA Oncology Webinar was organized on 29 August 2026, where 3 speakers discuss Towards Precision in Optimizing Cancer Care. 

This MDT Gulf Connect Webinar was organized on 26 August 2026, where 7 speakers discuss Qatar Edition: Optimizing Treatment Approaches for Early NSCLC without Genomic Alteration. 

This MDT Gulf Connect Webinar was organized on 24 August 2026, where 10 speakers discuss Kuwait Edition: Optimizing Treatment Approaches for Early NSCLC without Genomic Alteration. 

This APMEA Webinar was organized on 21 August 2026, where 6 speakers discuss The Right Test at the Right Time: Biomarker Testing for Precision Oncology. 

This EIOC Journal Club was organized on 22 July 2026, where 4 speakers discuss Latest Updates on Ovarian Cancer: Platinum-Resistant in Focus.

This EIOC Journal Club was organized on 16 July 2026, where 4 speakers discuss Optimizing Treatment Decision in mHSPC.

This EIOC Journal Club was organized on 01 July 2026, where 7 speakers discuss Management of aBC patients post CDK4/6i. 

This EIOC In Conversation Series was organized on 30 June 2026, where 2 speakers discuss on current paper revolving around The Rise of ADCs in mTNBC.

This EIOC Journal Club was organized on 29 June 2026, where 3 speakers discuss Updates in the Management of Paediatric and Adult Neurofibromatosis. 

This EIOC Journal Club was organized on 24 June 2026, where 7 speakers discuss Updates on 2L Metastatic Breast Cancer Management for PIK3CA/AKT/PTEN Alteration. 

This EIOC In Conversation Series was organized on 24 June 2026, where 2 speakers discuss on current paper revolving around Beyond EGFR TKIs in the management of advanced or metastatic EGFRm NSCLC. 

This EIOC Journal Club was organized on 19 June 2026, where 4 speakers discuss Post ASCO: Updates on Breast Cancer Management. 

This EIOC Journal Club was organized on 17 June 2026, where 6 speakers discuss Evolving Paradigms: The Role of Immunotherapy Across the Lung Cancer Spectrum.

This EIOC Journal Club was organized on 16 June 2026, where 6 speakers discuss CDK4/6i: Post ASCO Updates.

This EIOC Journal Club was organized on 11 June 2026, where 5 speakers discuss Redefining Outcomes in mNSCLC: The Expanding Role of Immunotherapy.

This EIOC Journal Club was organized on 10 June 2026, where 5 speakers discuss Key Upfront Strategies to Advance EGFRm NSCLC Care.

This EIOC Journal Club was organized on 09 June 2026, where 5 speakers discuss The Combination Era: Maximizing Outcomes with PARPi and Bevacizumab in Advanced Ovarian Cancer.

This EIOC Journal Club was organized on 08 June 2026, where 5 speakers discuss HER2 Next : Preparing for the Next Era in HER2+ mBC.

This EIOC Journal Club was organized on 19 May 2026, where 6 speakers discuss From Advanced to Early Breast Cancer: CDK4/6i Overview.

This EIOC Journal Club was organized on 18 May 2026, where 6 speakers discuss Updates & Cases discussion on the role of biomarkers in HR+/HER2- mBC “PIK3CA/AKT/PTEN alteration. 

This EIOC Journal Club was organized on 05 May 2026, where 6 speakers discuss From Risk to Action : How to interpret statistics to clinical practice in HR+ HER2- eBC. 

This EIOC Journal Club was organized on 30 April 2026, where 7 speakers discuss Evolving Paradigms: The Role of Immunotherapy Across Upper GI Cancers. 

This EIOC Journal Club was organized on 28 April 2026, where 7 speakers discuss Redefining Progression in ER+ve/HER2-ve aBC: Insights from Emerging Clinical Evidence. 

This EIOC Journal Club was organized on 27 April 2026, where 6 speakers discuss Management of Patients with AKTm post CDK4/6i.

This EIOC In Conversation Series was organized on 24 April 2026, where 2 speakers discuss on current paper revolving around Recent Advances and Future Treatment Landscape of Hr+ BC. 

This EIOC Journal Club was organized on 23 April 2026, where 5 speakers discuss Immune Checkpoint Inhibitors in r/m Endometrial Cancer. 

This EIOC Journal Club was organized on 22 April 2026, where 6 speakers discuss Emerging Evidence in Endocrine Resistance and SERD-Based Strategies: Clinical Perspectives and Future Directions.

This EIOC Journal Club was organized on 21 April 2026, where 5 speakers discuss Early and Metastatic Bladder Cancer Treatment Paradigm.

This EIOC Journal Club was organized on 13 April 2026, where 6 speakers discuss Translating Evidence to Care: BEV + PARPi for Advanced Ovarian Cancer Management.

This EIOC Journal Club was organized on 06 April 2026, where 7 speakers discuss on current paper revolving around Treatment Approaches for Early NSCLC Without Actionable Mutations.

This EIOC Journal Club was organized on 01 April 2026, where 4 speakers discuss on current paper revolving around Excellence in Prostate Cancer Care: Practical Insights from Key Trials.

This EIOC Journal Club was organized on 30 March 2026, where 7 speakers discuss on current paper revolving around Updates on 1L HER2+ Metastatic Breast Cancer.

The EIOC Journal Club was organized on 26 March 2026, where 4 speakers discuss on current paper revolving around Updates in the Management of Early Triple-Negative Breast Cancer (eTNBC).

This EIOC In Conversation Series was organized on 26 March 2026, where 2 speakers discuss on current paper revolving around The Road Ahead: Synthesizing Global Insights from SABCS & APBCS to Reshape Local Care.

The EIOC Onco Discussions Bahrain Chapter was organized on 17 March 2026, where 7 speakers discuss on current paper revolving around Management of Patients with AKTm Post CDK4/6i.

The EIOC Journal Club was organized on 16 March 2026, where 7 speakers discuss on current paper revolving around MDT Talks on Resectable GC & GEJ.

This EIOC In Conversation Series was organized on 09 March 2026, where 2 speakers discuss on current paper revolving around Updates from ASCO GI.

This EIOC In Conversation Series was organized on February 2026, where 2 speakers discuss on current paper revolving around Discussion on Trop-2 ADCs in 1L mTNBC.

This EIOC In Conversation Series was organized on February 2026, where 2 speakers discuss on current paper revolving around Managing 2L mTNBC & Pre-Treated mHR+/HER2.

This EIOC In Conversation Series was organized on February 2026, where 2 speakers discuss on current paper revolving around CDK4/6 Inhibition in eBC – The NATALEE Journey.

This EIOC Fireside Chat was organized on 1 November 2025, where Dr Shaheenah Dawood was in conversation with Prof Francois Clement Bidard to discuss on Managing HR+/HER2− Metastatic Breast Cancer in a Molecularly Driven Era. This session was supported by AstraZeneca.

This EIOC Fireside Chat was organized on 1 November 2025, where Dr Shaheenah Dawood was in conversation with Prof Stephen Johnston to discuss on Key Insights of Breast Cancer from ESMO 2025. This session was supported by Lilly.